November 2014 - The Reporter
The new initiative from UAB Employee Wellness encourages Blazers to stay active by visiting local green spaces in July and August 2024. Participants who visit three or more by the end of August will be entered to win one of three prize baskets.
Published in
Be Healthy
• Are you 18-70 years of age living with HIV, and want to be a part of a curative study?
• Is your viral load suppressed/undetectable?
• Are you able to receive an infusion or injection?
• Are you generally healthy?
• Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a HIV treatment study looking at an investigational way to effectively clear the HIV virus in areas of the body that standard antiretroviral treatment is unable to reach. You will receive one of two potential intervention methods. One intervention method is a broadly neutralizing antibody that is given to control growth of the HIV virus and to increase the body’s immune system response. The second intervention method is an injection (IL-15 Superagonist) designed to awaken the immune system, activate any dormant HIV virus, and then kill the virus. The duration of this study is approximately 84-112 weeks pending on which intervention method you receive. There is compensation at each study visit for time and travel.
Contact: If interested, please email kspraggins@uabmc.edu or call 205-934-9346
• Is your viral load suppressed/undetectable?
• Are you able to receive an infusion or injection?
• Are you generally healthy?
• Are you willing to temporarily stop taking antiretrovirals?
You may qualify for a HIV treatment study looking at an investigational way to effectively clear the HIV virus in areas of the body that standard antiretroviral treatment is unable to reach. You will receive one of two potential intervention methods. One intervention method is a broadly neutralizing antibody that is given to control growth of the HIV virus and to increase the body’s immune system response. The second intervention method is an injection (IL-15 Superagonist) designed to awaken the immune system, activate any dormant HIV virus, and then kill the virus. The duration of this study is approximately 84-112 weeks pending on which intervention method you receive. There is compensation at each study visit for time and travel.
Contact: If interested, please email kspraggins@uabmc.edu or call 205-934-9346
Published in
Clinical Trials
June 20, 2024
Why you should add emergency contacts in Oracle today
Find out how this confidential information can help you in the event of an illness, hospitalization or other emergency situation.
Published in
Tools & Technology
Anxiety is everywhere. But you can work on your emotional resiliency with these strategies from a course students are raving about. It is “the class I wish I had had,” instructors say.
Published in
Be Healthy
Amber Wagner, Ph.D., says AI tools are allowing her to accelerate student learning and can help future programmers keep pace with the constant change that has always been part of the profession.
Published in
Teaching & Learning
June 17, 2024
With Microsoft’s Copilot AI tool available to all Blazers, faculty prepare for fall 2024
“Using AI in the Classroom” workshops at the Center for Teaching and Learning are drawing lots of attention from faculty. CTL Director Amy Chatham, Ph.D., explains why and shares tips on a helpful new book and getting the most out of generative AI.
Published in
Tools & Technology
June 13, 2024
3 chosen as UAB VIPs for second-quarter 2024
John Huffstutler, Nancy Parsons and Angel Simmons are the second-quarter 2024 honorees of the UAB Values in Action Program. Nominations for third-quarter 2024 honorees are open through July 11.
Published in
Awards & Honors
June 12, 2024
Meet the leader of UAB’s Climate and Health Initiative
Zhen Cong, Ph.D., professor in the Department of Environmental Health Sciences in the School of Public Health, shares her work on disaster preparedness of older adults and why she wants all Blazers to take part in the initiative’s work.
Published in
Discoveries & Innovations
June 10, 2024
McDew to be new AVP & Sr. Title IX Coordinator
Andrea McDew, Ed.D., has been selected as the new assistant vice president and senior Title IX coordinator for the UAB Title IX Office. She has an extensive background in Title IX and university safety, most lately at Texas Christian University. McDew will begin at UAB on July 1.
Published in
Campus News
June 10, 2024
When developing a successful treatment means a loaded calendar and an “entirely new plan”
Clinical psychologist Aaron Fobian, Ph.D., created Retraining and Control Therapy, or ReACT, for patients with functional neurological disorder. It has helped hundreds reclaim their lives and led Fobian to develop an adaptive digital manual to expand use.
Published in
Advances
